Fmr LLC Nkarta, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Fmr LLC holds 67,549 shares of NKTX stock, worth $363,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,549

Previous 64,948 4.0%

Holding current value

$363,413

Previous $702,000 43.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $13,707 - $28,142	2,601 Added 4.0%	67,549 $399,000
Q1 2024 May 13, 2024	SELL	$5.59 - $15.71 $412,346 - $1.16 Million	-73,765 Reduced 53.18%	64,948 $702,000
Q4 2023 Feb 13, 2024	BUY	$1.31 - $6.6 $176,005 - $886,743	134,355 Added 3082.95%	138,713 $915,000
Q3 2023 Nov 13, 2023	BUY	$1.39 - $2.29 $1,862 - $3,068	1,340 Added 44.4%	4,358 $6,000
Q2 2023 Aug 11, 2023	BUY	$2.19 - $5.17 $2,012 - $4,751	919 Added 43.78%	3,018 $6,000
Q1 2023 May 11, 2023	SELL	$3.37 - $6.3 $819,610 - $1.53 Million	-243,208 Reduced 99.14%	2,099 $7,000
Q4 2022 Feb 13, 2023	SELL	$5.14 - $14.35 $2.29 Million - $6.4 Million	-445,857 Reduced 64.51%	245,307 $1.47 Million
Q3 2022 Nov 10, 2022	SELL	$12.27 - $18.39 $2.32 Million - $3.48 Million	-189,037 Reduced 21.48%	691,164 $9.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.77 - $19.44 $6.84 Million - $17.1 Million	880,033 Added 523829.16%	880,201 $10.8 Million
Q1 2022 May 13, 2022	BUY	$8.66 - $14.99 $1,454 - $2,518	168 New	168 $2,000
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $770,712 - $1.62 Million	-60,259 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.67 - $38.76 $186 - $271	-7 Reduced 0.01%	60,259 $1.68 Million
Q2 2021 Aug 13, 2021	BUY	$23.94 - $36.68 $1.44 Million - $2.21 Million	60,266 New	60,266 $1.91 Million

Others Institutions Holding NKTX

# of Institutions

120

Shares Held

66.2M

Call Options Held

142K

Put Options Held

43.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $262M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account